logo
episode-header-image
Feb 2024
36m 35s

Moderna and Drug Discovery With AI

bloomberg
About this episode
Vaccine-maker Moderna is also a data company, and that’s enabling it to use AI to drastically reduce drug-development times, Chief Information Officer Brad Miller tells Bloomberg Intelligence’s Sam Fazeli and Mandeep Singh. This episode of the Tech Disruptors podcast looks at a wide range of related topics, from the use of mRNA technology, to applying data f ... Show More
Up next
Today
Myers on Turning Compute Into an Asset Class
“The focus of the market and the industry is to make compute infrastructure in its own right a financeable asset class,” says Rich Myers, Morgan Stanley’s global head of structured products and private capital markets. Myers joins Bloomberg Intelligence’s Alexandra Davidov and Ro ... Show More
44m 3s
Oct 6
Unified Cyber Resilience in an Agentic AI Era
Agentic AI and autonomous threats are changing the cyber-resilience landscape and today, data protection and data security have converged. In this episode of the Tech Disruptors podcast, Commvault CEO Sanjay Mirchandani joins Bloomberg Intelligence technology analyst Derek Mogull ... Show More
34m 46s
Oct 1
Zillow CTO on How AI Changes Home Buying
Zillow Chief Technology Officer and founding team member David Beitel joins Bloomberg Intelligence analyst Nicole D’Souza on this episode of the Tech Disruptors podcast to discuss how artificial intelligence is reshaping the home-buying journey. The conversation explores how Zill ... Show More
34m 55s
Recommended Episodes
Jul 2025
How Bristol Myers Squibb Is Accelerating Drug Development With AI - Ep. 264
Greg Meyers, chief digital and technology officer at Bristol Myers Squibb, explains how AI is transforming pharmaceutical research from hypothesis-driven hunches to data-driven discoveries. Learn how the company is using computational chemistry to engineer breakthrough therapies ... Show More
31m 40s
Aug 2024
Recursion CEO Chris Gibson on Accelerating the Biopharmaceutical Industry With AI - Ep. 230
Techbio is a field combining data, technology and biology to enhance scientific processes — and AI has the potential to supercharge the biopharmaceutical industry further. In this episode of NVIDIA’s AI Podcast, host Noah Kravitz speaks with Chris Gibson, cofounder and CEO of Rec ... Show More
37m 55s
Oct 2025
How CytoReason is Bridging the Data Insight Gap to Accelerate Healthcare Breakthroughs - Ep. 276
Shai Shen-Orr, co-founder and chief scientist at CytoReason and professor at the Technion, talks about the next frontier in healthcare: disease modeling. Shai shares how CytoReason bridges the gap between exploding biological data and actionable insight, powering smarter, faster ... Show More
35m 12s
Mar 2025
AI in Biopharma Innovation and Regulatory Challenges - with Nishtha Jain of Takeda Pharmaceuticals
<p>Today's guest is Nishtha Jain, Head of Innovation and Digital Technology at Takeda Pharmaceuticals. Nistha returns to the program to discuss the transformative impact of AI across the pharmaceutical value chain. She and Emerj Editorial Director Matthew DeMello explore how AI i ... Show More
26m 36s
Apr 2025
Isomorphic Labs Discusses AI-Driven Drug Discovery and the Future of Medicine - Ep. 252
Max Jaderberg and Sergei Yakneen from Isomorphic Labs discuss how AI is enhancing drug discovery by treating biology as an information processing system. They share how advanced AI models like AlphaFold 3 are accelerating the pipeline and paving the way for a future of precision ... Show More
39m 25s
Oct 2025
How Agentic AI Shortens Drug Development and Boosts Patient Outcomes - Ep. 277
Learn how agentic AI is transforming pharma. IQVIA’s Raja Shankar and Avinob Roy share how intelligent automation accelerates clinical trials, improves commercial strategy, and powers better patient care — turning healthcare data into outcomes at scale. Listen to the full archive ... Show More
33m 38s
Sep 2023
Moderna CEO Talks New Drugs
Moderna CEO Stephane Bancel talks about the Moderna vaccine, drug prices, and future of the company with Bloomberg's Paul Sweeny and Matt Miller. See omnystudio.com/listener for privacy information. 
9m 22s
May 2023
Bojan Tunguz, Johnny Israeli on How AI and Crowdsourcing Can Advance Vaccine Distribution - Ep. 195
Artificial intelligence is teaming up with crowdsourcing to improve the thermo-stability of mRNA vaccines, making distribution more accessible worldwide. In this episode of NVIDIA's AI podcast, host Noah Kravitz interviewed Bojan Tunguz, a physicist and senior system software en ... Show More
33m 5s
Feb 2025
Understanding AI's Expanding Role in Drug Discovery and Life Sciences R&D - Liran Belenzon of BenchSci
<p><span data-preserver-spaces="true">Today's guest is Liran Belenzon, Co-founder and CEO of BenchSci. BenchSci is a global leader in AI solutions for preclinical R&D that helps decipher complex biomedical research using proprietary technology. Liran joins us to discuss how AI is ... Show More
19m 3s
Jul 2024
Driving Efficiencies Across the Life Sciences Value Chain with AI in Drug Development - with Nishtha Jain of Takeda
<p>Today's guest is Nishtha Jain, Head of Innovation and Digital Technology at Takeda Pharmaceuticals. Her role expands across Global R&D Quality in driving digital and data initiatives from concept to execution, leveraging emerging technologies and design principles. She joins u ... Show More
26m 41s
Listen to millions of songs and podcasts on Anghami